XML 62 R39.htm IDEA: XBRL DOCUMENT v3.6.0.2
Business segment information (Tables)
12 Months Ended
Dec. 31, 2016
Segment Reporting [Abstract]  
Schedule of Net Sales by Reporting Segment

The table below presents net sales by reporting segment:

 

 

 

Year Ended December 31,

 

 

 

2016

 

 

2015

 

 

2014

 

(U.S. Dollars, in thousands)

 

Net Sales

 

 

Percent of

Total Net

Sales

 

 

Net Sales

 

 

Percent of

Total Net

Sales

 

 

Net Sales

 

 

Percent of

Total Net

Sales

 

BioStim

 

$

176,561

 

 

 

43.1

%

 

$

164,955

 

 

 

41.6

%

 

$

154,676

 

 

 

38.5

%

Biologics

 

 

57,912

 

 

 

14.1

%

 

 

59,832

 

 

 

15.1

%

 

 

55,881

 

 

 

13.9

%

Extremity Fixation

 

 

102,683

 

 

 

25.1

%

 

 

96,034

 

 

 

24.2

%

 

 

109,678

 

 

 

27.3

%

Spine Fixation

 

 

72,632

 

 

 

17.7

%

 

 

75,668

 

 

 

19.1

%

 

 

82,042

 

 

 

20.4

%

Net sales

 

$

409,788

 

 

 

100.0

%

 

$

396,489

 

 

 

100.0

%

 

$

402,277

 

 

 

100.0

%

 

Summary of Net Margin by Reporting Segment

The following table presents net margin by reporting segment:

 

 

 

Year Ended December 31,

 

(U.S. Dollars, in thousands)

 

2016

 

 

2015

 

 

2014

 

BioStim

 

$

75,469

 

 

$

67,878

 

 

$

66,096

 

Biologics

 

 

26,891

 

 

 

27,226

 

 

 

26,629

 

Extremity Fixation

 

 

30,526

 

 

 

29,493

 

 

 

31,586

 

Spine Fixation

 

 

8,650

 

 

 

8,547

 

 

 

14,243

 

Corporate

 

 

(888

)

 

 

(1,260

)

 

 

(1,736

)

Net margin

 

$

140,648

 

 

$

131,884

 

 

$

136,818

 

General and administrative

 

 

74,404

 

 

 

87,157

 

 

 

79,074

 

Research and development

 

 

28,803

 

 

 

26,389

 

 

 

24,994

 

Restatements and related costs

 

 

2,005

 

 

 

9,083

 

 

 

15,614

 

Charges related to U.S. Government resolutions

 

 

14,369

 

 

 

 

 

 

 

Operating income

 

$

21,067

 

 

$

9,255

 

 

$

17,136

 

 

Schedule of Depreciation and Amortization by Reporting Segment

The following table presents depreciation and amortization by reporting segment:

 

 

 

Year Ended December 31,

 

(U.S. Dollars, in thousands)

 

2016

 

 

2015

 

 

2014

 

BioStim

 

$

2,754

 

 

$

2,933

 

 

$

1,623

 

Biologics

 

 

1,011

 

 

 

1,157

 

 

 

1,161

 

Extremity Fixation

 

 

5,742

 

 

 

6,636

 

 

 

8,442

 

Spine Fixation

 

 

8,118

 

 

 

10,050

 

 

 

11,711

 

Corporate

 

 

3,216

 

 

 

147

 

 

 

(59

)

Total

 

$

20,841

 

 

$

20,923

 

 

$

22,878

 

 

Summary of Net Sales by Geographic Destination

The following data includes net sales by geographic destination:

 

(U.S. Dollars, in thousands)

 

2016

 

 

2015

 

 

2014

 

U.S.

 

$

316,873

 

 

$

305,505

 

 

$

294,682

 

Italy

 

 

16,664

 

 

 

15,655

 

 

 

19,573

 

United Kingdom

 

 

10,362

 

 

 

11,376

 

 

 

11,402

 

Brazil

 

 

11,334

 

 

 

13,512

 

 

 

19,633

 

Others

 

 

54,555

 

 

 

50,441

 

 

 

56,987

 

Net sales

 

$

409,788

 

 

$

396,489

 

 

$

402,277

 

 

Summary of Property, Plant and Equipment of Reporting Segments by Geographic Area

The following data includes property, plant and equipment by geographic area:

 

(U.S. Dollars, in thousands)

 

2016

 

 

2015

 

U.S.

 

$

38,398

 

 

$

42,534

 

Italy

 

 

7,013

 

 

 

6,015

 

United Kingdom

 

 

617

 

 

 

998

 

Brazil

 

 

769

 

 

 

1,036

 

Others

 

 

2,119

 

 

 

1,723

 

Total

 

$

48,916

 

 

$

52,306